MedPath

Tetryzoline

Generic Name
Tetryzoline
Brand Names
Colirio Ocusan, Visine
Drug Type
Small Molecule
Chemical Formula
C13H16N2
CAS Number
84-22-0
Unique Ingredient Identifier
S9U025Y077

Overview

Tetryzoline, also known as tetrahydrozoline, is a derivative of imidazoline with central and peripheral alpha (α)-adrenergic properties. Available since the 1950s, tetryzoline is a selective α-receptor agonist that is used as an ocular and nasal decongestant. Tetryzoline is found in a wide array of over-the-counter eye drops, including the most common brand, Visine. Tetryzoline is also found in combination products with other lubricants and anti-irritants, such as povidone, polyethylene glycol 400, dextran, and zinc sulfate. It is also used in combination with other drug classes, such as antihistamines, corticosteroids, and glucocorticoids in other countries. Tetryzoline is also found in nasal spray under the trade name Tyzine, which is used for decongestion of nasal and nasopharyngeal mucosa. As it causes profound sedation in children and adults, tetryzoline is increasingly becoming scrutinized for possible drug overdose and toxicity from accidental ingestion. It has also been misused for non-therapeutic purposes as a causative drug for several cases of drug-facilitated sexual assault.

Indication

用于过敏性结膜炎、急性或慢性结膜炎,也可用于花粉症所引起的充血性结膜炎、灼热及痒感、眼疲倦。亦可用于由于配戴眼镜、阅读、看电视、暗室工作引起的视疲劳。

Associated Conditions

  • Active, Symptomatic Blepharitis
  • Allergic Conjunctivitis (AC)
  • Blepharitis allergic
  • Blepharoconjunctivitis
  • Chalazion
  • Conjunctivitis
  • Conjunctivitis, Vernal
  • Dacryocystitis
  • Dry Eyes
  • Episcleritis
  • Eye allergy
  • Eye pruritus
  • Eye redness
  • Eyelid folliculitis
  • Keratitis
  • Keratoconjunctivitis
  • Nasal Congestion
  • Nasal oedema
  • Ocular Inflammation
  • Ocular Irritation
  • Pterygium
  • Red eye
  • Rhinopharyngitis
  • Scleritis
  • Sinusitis
  • Acute Rhinitis
  • Bacterial blepharitis
  • Conjunctival hyperemia
  • Eye discomfort
  • Sensation of burning in the eyes
  • Subacute Rhinitis
  • Swelling of the eyes

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
The Kroger Co.
30142-574
OPHTHALMIC
0.05 g in 100 mL
1/1/2024
Discount Drug Mart, Inc.
53943-490
OPHTHALMIC
0.05 g in 100 mL
1/1/2024
HEB Grocery Company, LP
37808-577
OPHTHALMIC
0.05 g in 100 mL
1/1/2024
Salado Sales, Inc.
57243-068
OPHTHALMIC
0.05 g in 100 mL
1/1/2024
Morning Star OTC
53209-6001
OPHTHALMIC
0.5 mg in 1 mL
6/16/2025
DLC Laboratories, Inc.
24286-1575
OPHTHALMIC
0.5 mg in 1 mL
4/18/2025
Preferred PHarmaceuticals Inc.
68788-8635
OPHTHALMIC
0.05 g in 100 mL
5/7/2025
Harris Teeter, LLC.P
69256-977
OPHTHALMIC
0.05 g in 100 mL
1/1/2024
United Natural Foods, Inc.
83455-210
OPHTHALMIC
0.05 g in 100 mL
1/1/2024
Valu Merchandisers Company
63941-139
OPHTHALMIC
0.05 g in 100 mL
1/1/2024

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
ALOSYN EYE DROPS
SIN13400P
SOLUTION, STERILE
0.40MG/ML
1/24/2008
OPTIZOLINE EYE DROPS 0.05%
SIN06918P
SOLUTION
0.05%
3/23/1992

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

© Copyright 2025. All Rights Reserved by MedPath